Thomas Xu, MD
Pain Medicine · Atlanta, GANPI 1063766160
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,612 of the $6,542 with a category attached, or 85.8%. Nevro Corp. accounts for 66.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $2,984 and has fallen 84.7% since, to $455 in 2025.
Across 140 payments — averaging $46.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$4K
- Boston Scientific$517
- Intuitive Surgical$206
- Azurity Pharmaceuticals, Inc.$205
- Arbor Pharmaceuticals, Inc.$189
- Abbott$176
- plus $870 from 15 others
What the payments were for
- Travel & lodging$93014%
- Food & beverage$5,61286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 70 | $4,378 |
| Boston Scientific | 13 | $517 |
| Intuitive Surgical | 2 | $206 |
| Azurity Pharmaceuticals, Inc. | 11 | $205 |
| Arbor Pharmaceuticals, Inc. | 10 | $189 |
| Abbott | 9 | $176 |
| Avanos Medical | 2 | $163 |
| Integra Lifesciences Corporation | 1 | $142 |
| AbbVie | 4 | $105 |
| Kerecis Limited | 1 | $94 |
| UCB, Inc. | 3 | $79 |
| Assertio Therapeutics, Inc. | 3 | $50 |
| Nalu Medical, Inc. | 1 | $45 |
| Merit Medical Systems Inc | 2 | $35 |
| Sanofi | 2 | $30 |
| Curonix LLC | 1 | $29 |
| SPR Therapeutics, Inc | 1 | $24 |
| Biotronik NRO, Inc. | 1 | $23 |
| Amgen | 1 | $19 |
| Biogen | 1 | $18 |
| Greenwich Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,542 in reported general payments places this provider in the 75th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 83 | $1,523 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $1,025 |
| Pregabalin | 25 | $524 |
| Tramadol Hcl | 67 | $312 |
| Diclofenac Sodium | 27 | $233 |
| Methylprednisolone | 16 | $97 |
| Tizanidine Hcl | 14 | $71 |
| Meloxicam | 20 | $67 |
| Diazepam | 13 | $7 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Atlanta
- Susheel DuaAtlanta$36K
- Muhammad QadriAtlanta$14K
- Evesha KenlynAtlanta$9K
- Ashley RogersAtlanta$5K
- Rutvij ShahColumbus$86K
- Siddardth UmapathyFort Eisenhower$41K
- Subodh AgrawalAthens$34K
- Jose MathewLawrenceville$27K
- Zhuo SunAugusta$26K
- Maged HamzaGainesville$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.